Duration of Antibiotic Treatment in Community-Acquired Pneumonia: A Multicenter Randomized Clinical Trial.
about
Using Procalcitonin to Guide Antibiotic Therapy.The New Antibiotic Mantra-"Shorter Is Better".A longitudinal modelling study estimates acute symptoms of community acquired pneumonia recover to baseline by 10 days.Significant Publications on Infectious Diseases Pharmacotherapy in 2016.To which extent can we decrease antibiotic duration in critically ill patients?An update on the pharmacotherapeutic management of lower respiratory tract infections.Antibiotic stewardship in community-acquired pneumonia.Shorter antibiotic courses in community-acquired pneumonia-ready for prime time.Antibiotic therapy, supportive treatment and management of immunomodulation-inflammation response in community acquired pneumonia: review of recommendationsIs it time to stop counselling patients to "finish the course of antibiotics"?PURLs: When to "CAP" off treatment for pneumonia.Informing antimicrobial stewardship: factors associated with inappropriate antimicrobial prescribing in primary care.Study design considerations for the Standardized Treatment of Pulmonary Exacerbations 2 (STOP2): A trial to compare intravenous antibiotic treatment durations in CF.Short-course antimicrobial therapy for paediatric respiratory infections (SAFER): study protocol for a randomized controlled trial.Duration of Antibiotic Use among Adults with Uncomplicated Community-Acquired Pneumonia Requiring Hospitalization in the United States.Adaptive Designs for Clinical Trials: Application to Healthcare Epidemiology Research.Is there any difference in quality of prescribing between antibacterials and antifungals? Results from the first global point prevalence study (Global PPS) of antimicrobial consumption and resistance from 53 countries.Investigational drugs in phase I and phase II clinical trials for the treatment of community-acquired pneumonia.Antimicrobial stewardship by family physicians.Community-Acquired Pneumonia in Adults.Appropriate antibiotic management of bacterial lower respiratory tract infections
P2860
Q33629591-74AB85DA-C26E-4B6A-A6DC-C47B2BE75ECEQ37583610-D724D540-6C2D-4166-A6AA-5527CCBD93CAQ38670460-302D27A7-361F-41FA-9C8A-969D3F976C15Q40067736-34F1338B-1612-4209-B492-55078DE8A759Q40081236-BDC1E280-9FF1-4DE6-AECA-71CB14722E16Q40222424-60ABFB68-932C-4101-801A-71DE10B04427Q40400146-8ACB2306-717B-4707-B86C-433F0FE2E02FQ42331416-141FD002-8783-4739-91A0-D8FAD80FAA4EQ42370479-8D1E71B7-7360-47EB-864A-07DAB0327755Q46512565-301D6C91-6D0D-4ECC-B311-1BA4122C02AEQ47141273-ABE16809-EA52-4CE1-8CC1-B44CDCC3108FQ47316678-B96CA420-FD3D-4213-9012-2C7C81F1F8A7Q47422154-FF42B592-09C7-4B89-A928-9873C357C692Q47547063-D898F159-A0ED-4705-8D32-2BC6C870076EQ47617096-6D29E7EE-2DBA-4CCE-A73D-D7D8AFC7ABC6Q47625359-CCCC5465-AA9C-4157-BDB1-E72FAFF7D088Q47677638-9FFCD30E-289E-422F-9DA9-6FF86910865BQ47761002-E238840B-AFFD-4EE3-AA04-6FEEDA6F6A4AQ54980067-B8AC15B6-8FD2-4944-A52B-E30066FA592DQ55073534-B78BB861-B147-4B1F-B94B-3C355FF57923Q56942464-C13CAFA2-F586-47CC-970F-1AB39C1B3A7C
P2860
Duration of Antibiotic Treatment in Community-Acquired Pneumonia: A Multicenter Randomized Clinical Trial.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Duration of Antibiotic Treatme ...... ter Randomized Clinical Trial.
@en
type
label
Duration of Antibiotic Treatme ...... ter Randomized Clinical Trial.
@en
prefLabel
Duration of Antibiotic Treatme ...... ter Randomized Clinical Trial.
@en
P2093
P1476
Duration of Antibiotic Treatme ...... ter Randomized Clinical Trial.
@en
P2093
Alberto Capelastegui
Amaia Bilbao
Ane Uranga
Ignacio Arriaga
Jesus Camino
Jose Luis Lobo
Juan Nuñez
Laura Tomás
Maider Intxausti
Pedro P España
P304
P356
10.1001/JAMAINTERNMED.2016.3633
P577
2016-07-25T00:00:00Z